Lawfare March 6, 2023
On Feb. 1, the Federal Trade Commission (FTC) announced an enforcement action against prescription drug provider and telehealth company GoodRx, for “failing to notify consumers and others of its unauthorized disclosures of consumers’ personal health information to Facebook, Google, and other companies.” Samuel Levine, the director of the FTC’s Bureau of Consumer Protection, said in the press release that “the FTC is serving notice that it will use all of its legal authority to protect American consumers’ sensitive data from misuse and illegal exploitation.” Along with a $1.5 million penalty, the proposed order would prohibit GoodRx from sharing its users’ health information with third parties for advertising purposes, among other safeguards.
The FTC’s enforcement action against GoodRx is significant in...
Today's Sponsors
Today's Sponsor